ARDS Aridis Pharmaceuticals received a grant award from the Bill & Melinda Gates Foundation to evaluate the application of Aridis' inhaled formulation technology to deliver cost-effective monoclonal antibodies (mAbs) against influenza and SARS-CoV2.
Aridis Pharmaceuticals is a stock with a mk cap of only 28.249Mil.
Before Aridis, Bill & Melinda Gates Foundation...
